Sequential screening for lung cancer in a high-risk group: randomised controlled trial

Stephen G. Spiro, Pallav L. Shah, Robert C. Rintoul, Jeremy George, Samuel Janes, Matthew Callister, Marco Novelli, Penny Shaw, Gabrijela Kocjan, Chris Griffiths, Mary Falzon, Richard Booton, Nicholas Magee, Michael Peake, Paul Dhillon, Kishore Sridharan, Andrew G. Nicholson, Simon Padley, Magali N. Taylor, Asia Ahmed, Jack Allen, Yenting Ngai, Nyasha Chinyanganya, Victoria Ashford-Turner, Sarah Lewis, Dahmane Oukrif, Pamela Rabbitts, Nicholas Counsell, Allan Hackshaw

Source: Eur Respir J, 54 (4) 1900581; 10.1183/13993003.00581-2019
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Stephen G. Spiro, Pallav L. Shah, Robert C. Rintoul, Jeremy George, Samuel Janes, Matthew Callister, Marco Novelli, Penny Shaw, Gabrijela Kocjan, Chris Griffiths, Mary Falzon, Richard Booton, Nicholas Magee, Michael Peake, Paul Dhillon, Kishore Sridharan, Andrew G. Nicholson, Simon Padley, Magali N. Taylor, Asia Ahmed, Jack Allen, Yenting Ngai, Nyasha Chinyanganya, Victoria Ashford-Turner, Sarah Lewis, Dahmane Oukrif, Pamela Rabbitts, Nicholas Counsell, Allan Hackshaw. Sequential screening for lung cancer in a high-risk group: randomised controlled trial. Eur Respir J, 54 (4) 1900581; 10.1183/13993003.00581-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Home-based rehabilitation in inoperable lung cancer: a randomised controlled trial
Source: International Congress 2018 – Physiotherapy care for patients with acute and chronic respiratory conditions
Year: 2018




Bevacizumab as first line treatment for advanced non-small cell lung cancer (NSCLC): a meta-analysis of randomised placebo-controlled trials (RCTs)
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008



A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
Source: Eur Respir J 2016; 48: 320-330
Year: 2016



Effects of early rehabilitation following lung transplantation: a randomized controlled trial
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009


Pilot trial of the ICHOM lung cancer standard set
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017

Determinants of completion of a home-based rehabilitation program in patients awaiting lung surgery for lung cancer : a prospective observational multicenter study
Source: Virtual Congress 2020 – Thoracic surgery: malignancies
Year: 2020


Short-time exercise-induced rehabilitation in non-small cell lung cancer patients during in-hospital chemotherapy treatment: a randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design
Source: Eur Respir J 2015; 45: 511-524
Year: 2015



Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT)
Source: International Congress 2017 – Many faces of asthma assessment
Year: 2017



Physical activity level during the first three days after lung cancer surgery improves with physiotherapy: a randomized controlled trial
Source: International Congress 2018 – Physiotherapy care for patients with acute and chronic respiratory conditions
Year: 2018



Helium-hyperoxia a novel treatment for optimizing pulmonary rehabilitation: a randomized controlled trial
Source: Eur Respir J 2007; 30: Suppl. 51, 327s
Year: 2007

A self-management programme for COPD: a randomised controlled trial
Source: Eur Respir J 2014; 44: 1538-1547
Year: 2014



Effect of ADL- training for persons with COPD: A randomized controlled trial
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011


Resistance arm training in patients with COPD: A randomized controlled trial
Source: Annual Congress 2010 - Exercise training and pulmonary rehabilitation
Year: 2010

Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Long-term effects of high-intensity training after lung cancer surgery — A five-years follow-up of a randomized controlled trial
Source: International Congress 2018 – Exercise is medicine: testing and treating patients with some effort
Year: 2018



A randomised controlled trial of lung volume recruitment in people with neuromuscular disease
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Positive effect of MusiCure on patients undergoing bronchochoscopy - A randomized controlled trial
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016